Price movement over the last 24 hours
AdaptHealth Corp vs Flagstar Bank NA — how do they compare? AdaptHealth Corp trades at $10.1 (market cap $1.38B), while Flagstar Bank NA trades at $14.45 (market cap $6.15B). The key difference: Flagstar Bank NA is far larger — about 4.5× AdaptHealth Corp's market cap, and Flagstar Bank NA pays a 0.27% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | FLG | |
|---|---|---|
Market Cap | $1.38B | $6.15B |
Sector | Health | Financials |
52-Week High | $13.38 | $15.28 |
52-Week Low | $8.68 | $10.72 |
Enterprise Value | $3.33B | — |
Dividend Yield | — | 0.27% |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Flagstar Bank (FLG) trades at $14.84, up 1.71% today, showing technical bullish momentum with strong moving average signals. The company has delivered two consecutive quarterly earnings beats (Q4 2025 and Q1 2026) and recently announced a proprietary technology transformation. Despite negative profitability metrics, the stock trades below book value (P/B 0.81) and analysts maintain a 50/50 buy/hold split with a $16.94 consensus target.
FLG presents a turnaround story with improving fundamentals but carries execution risks. The bank's shift toward profitability and technology investments offers potential upside, though negative margins and high interest expenses remain concerns. With the current price below analyst targets, the stock offers value potential but requires careful monitoring of credit quality and operational improvements.
Trailing returns across standard periods
Latest headlines on both assets
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →